Basal Cell Carcinoma
5 competing products in clinical development for Basal Cell Carcinoma.
Pipeline by Phase
Pre-clinical2
Phase 23
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Vismodegib | Sun Pharmaceutical | Phase 2 | Recruiting | 42 |
| Cemiplimab Injection [Libtayo] | Sun Pharmaceutical | Phase 2 | Active | 39 |
| Vismodegib + Sonidegib | Sun Pharmaceutical | Pre-clinical | Recruiting | 33 |
| sonidegib | Sun Pharmaceutical | Pre-clinical | Completed | 26 |
| Part 1: VP-315 3 Day Dosing/Week + Part 2: VP-315 3 Day Dosing/Week - Loading Dose + Part 2: VP-315 3 Day Dosing/Week - No Loading Dose + Part 2: VP-315 2 Day Dosing/Week - Split Dose + Part 2: VP-315 3 Day Dosing/Week - Split Dose | Verrica Pharmaceuticals | Phase 2 | Completed | 25 |